- Kenneth F Schulz, vice president of quantitative sciences1,
- Douglas G Altman, director2,
- David Moher, director3
- 1Family Health International, Research Triangle Park, North Carolina, 27709 USA
- 2Centre for Statistics in Medicine, Wolfson College Annexe, Oxford OX2 6UD
- 3Chalmers Research Group, Children's Hospital of Eastern Ontario (CHEO) Research Institute, Ottawa, ON, Canada K1H 8L1
- kschulz{at}fhi.org
We agree with Morris et al that “blinding” terminology is probably inappropriate in ophthalmological settings.1 However, we disagree that these settings should ordain terminology for all randomised trials. They describe “masking” done in 1784 and provide dictionary definitions of masking and blinding to buttress their argument for using masking terminology. The techniques used in 1784, however, were …
Sign in
Personal subscribers, sign in here:
Article access
Article access for 1 day
Purchase this article for £20 $30 €32*
The PDF version can be downloaded as your personal record
CiteULike
Connotea
Del.icio.us
Digg
Facebook
Reddit
Technorati
Twitter
Stumbleupon
Rapid responses
Latest Responses
The decline in the breast cancer incidence is 1.2% and it is not significant.
Published 10 February 2012
'twas ever thus
Published 10 February 2012
The value of historic human remains
Published 10 February 2012
In Praise of British Literature
Published 10 February 2012
Is real shared decision making possible?
Published 10 February 2012
Most responses
Does anyone understand the government’s plan for the NHS? (17 responses)
Published 17 Jan 2012
Bad medicine: medical nutrition (15 responses)
Published 18 Jan 2012
Shared decision making: really putting patients at the centre of healthcare (7 responses)
Published 27 Jan 2012
Why legislation is necessary for my health reforms (7 responses)
Published 1 Feb 2012
Search for evidence goes on (5 responses)
Published 17 Jan 2012